1. Home
  2. PSTV vs NXPL Comparison

PSTV vs NXPL Comparison

Compare PSTV & NXPL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • PSTV
  • NXPL
  • Stock Information
  • Founded
  • PSTV 1996
  • NXPL 1997
  • Country
  • PSTV United States
  • NXPL United States
  • Employees
  • PSTV N/A
  • NXPL N/A
  • Industry
  • PSTV Medical/Dental Instruments
  • NXPL Telecommunications Equipment
  • Sector
  • PSTV Health Care
  • NXPL Telecommunications
  • Exchange
  • PSTV Nasdaq
  • NXPL Nasdaq
  • Market Cap
  • PSTV 17.0M
  • NXPL 17.9M
  • IPO Year
  • PSTV N/A
  • NXPL N/A
  • Fundamental
  • Price
  • PSTV $0.70
  • NXPL $0.75
  • Analyst Decision
  • PSTV Strong Buy
  • NXPL
  • Analyst Count
  • PSTV 3
  • NXPL 0
  • Target Price
  • PSTV $10.83
  • NXPL N/A
  • AVG Volume (30 Days)
  • PSTV 19.1M
  • NXPL 60.6K
  • Earning Date
  • PSTV 08-22-2025
  • NXPL 08-14-2025
  • Dividend Yield
  • PSTV N/A
  • NXPL N/A
  • EPS Growth
  • PSTV N/A
  • NXPL N/A
  • EPS
  • PSTV N/A
  • NXPL N/A
  • Revenue
  • PSTV $5,206,000.00
  • NXPL $62,515,000.00
  • Revenue This Year
  • PSTV $8.26
  • NXPL N/A
  • Revenue Next Year
  • PSTV $8.39
  • NXPL N/A
  • P/E Ratio
  • PSTV N/A
  • NXPL N/A
  • Revenue Growth
  • PSTV N/A
  • NXPL 19.36
  • 52 Week Low
  • PSTV $0.16
  • NXPL $0.43
  • 52 Week High
  • PSTV $2.31
  • NXPL $2.30
  • Technical
  • Relative Strength Index (RSI)
  • PSTV 60.91
  • NXPL 51.44
  • Support Level
  • PSTV $0.45
  • NXPL $0.72
  • Resistance Level
  • PSTV $0.90
  • NXPL $0.79
  • Average True Range (ATR)
  • PSTV 0.12
  • NXPL 0.05
  • MACD
  • PSTV 0.02
  • NXPL -0.00
  • Stochastic Oscillator
  • PSTV 57.45
  • NXPL 34.48

About PSTV PLUS THERAPEUTICS Inc.

Plus Therapeutics Inc is a clinical-stage pharmaceutical company that focuses on discovering, developing, and delivering complex treatments for patients with cancer and rare diseases. The company is working on a range of potential products, with its main programs targeting recurrent glioblastoma (GBM) and leptomeningeal metastases (LM). One of its key candidates, rhenium (186Re) obisbemeda, is specifically designed to treat central nervous system (CNS) cancers such as GBM, LM, and pediatric brain cancers (PBC).

About NXPL NextPlat Corp

NextPlat Corp is an e-commerce and healthcare company. Its e-commerce venues form an effective network serving thousands of consumers, enterprises, and governments. Its healthcare business is focused on improving the lives of patients with complex chronic diseases through patient and provider engagement and their partnerships with payors, pharmaceutical manufacturers, and distributors, offering a broad range of solutions to address the dispensing, delivery, dosing, and reimbursement of clinically intensive, high-cost drugs. The company operates in two segments: e-Commerce Operations involves acquiring and leasing an e-commerce platform; and Healthcare Operations provides TPA, data management, COVID-19 related diagnostics and vaccinations, prescription pharmaceuticals, and Others.

Share on Social Networks: